Commonly used lab tests should be available as individual tests. For example, fibrinogen, amylase, lipase, ADMA/SDMA, methylmalonic acid, and vitamin B6 should be available without requiring the purchase of an entire panel.

Clinicians should be able to add these individual markers to their own customized panels, which can already be costly. Patients should not have to purchase an additional full panel solely to obtain a few specific markers.